 | Up a level |
Journal Article
Blohmer, Jens-Uwe, Link, Theresa, Reinisch, Mattea, Just, Marianne, Untch, Michael, Stotzer, Oliver, Fasching, Peter A., Schneeweiss, Andreas, Wimberger, Pauline, Seiler, Sabine, Huober, Jens, Thill, Marc, Jackisch, Christian, Rhiem, Kerstin, Solbach, Christine, Hanusch, Claus, Seither, Fenja, Denkert, Carsten, Engels, Knut, Nekljudova, Valentina and Loibl, Sibylle (2022). Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer The GeparX 2 x 2 Randomized Clinical Trial. JAMA Oncol., 8 (7). S. 1010 - 1019. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445
Denkert, Carsten, Seither, Fenja, Schneeweiss, Andreas, Link, Theresa, Blohmer, Jens-Uwe, Just, Marianne, Wimberger, Pauline, Forberger, Almuth, Tesch, Hans, Jackisch, Christian, Schmatloch, Sabine, Reinisch, Mattea, Solomayer, Erich F., Schmitt, Wolfgang D., Hanusch, Claus, Fasching, Peter A., Luebbe, Kristina, Solbach, Christine, Huober, Jens, Rhiem, Kerstin, Marme, Frederik, Reimer, Toralf, Schmidt, Marcus 
ORCID: 0000-0003-1365-2414, Sinn, Bruno, V, Janni, Wolfgang, Stickeler, Elmar, Michel, Laura, Stoetzer, Oliver, Hahnen, Eric, Furlanetto, Jenny, Seiler, Sabine, Nekljudova, Valentina, Untch, Michael and Loibl, Sibylle
(2021).
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol., 22 (8).
S. 1151 - 1162.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Engel, Christoph ORCID: 0000-0002-7247-282X, Rhiem, Kerstin, Hahnen, Eric, Loibl, Sibylle, Weber, Karsten E., Seiler, Sabine, Zachariae, Silke, Hauke, Jan, Wappenschmidt, Barbara, Waha, Anke, Bluemcke, Britta, Kiechle, Marion, Meindl, Alfons, Niederacher, Dieter, Bartram, Claus R., Speiser, Dorothee, Schlegelberger, Brigitte, Arnold, Norbert ORCID: 0000-0003-4523-8808, Wieacker, Peter, Leinert, Elena, Gehrig, Andrea, Briest, Susanne, Kast, Karin, Riess, Olaf, Emons, Guenter, Weber, Bernhard H. F., Engel, Jutta and Schmutzler, Rita K.
(2018).
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history.
BMC Cancer, 18.
LONDON:
BIOMED CENTRAL LTD.
ISSN 1471-2407
Loibl, Sibylle, Jackisch, Christian, Seiler, Sabine, Rastogi, Priya, Huober, Lens, Denkert, Carsten, Schneeweiss, Andreas, Hanusch, Claus, Fasching, Peter A., Blohmer, Jens-Uwe, Untch, Michael, Rhiem, Kerstin, Solbach, Christine, Nekljudova, Valentina, Costantino, Joseph, Wolmark, Norman and Geyer, Charles (2020). A Randomized, Double-Blind, Phase III Trial of Neoadjuvant Chemotherapy (NACT) with atezolizumab/Placebo in Patients with Triple-Negative Breast Cancer (TNBC) Followed by Adjuvant Continuation of atezolizumab/Placebo (Gepardouze). Oncol. Res. Treat., 43. S. 24 - 26. BASEL: KARGER. ISSN 2296-5262
Tesch, Hans, Loibl, Sibylle, Kast, Karin, Jackisch, Christian, Mobuss, Volker, Buchen, Stefanie, Untch, Michael, Hanusch, Claus, Seiler, Sabine, Weigel, Michael, Fasching, Peter A., Rhiem, Kerstin, Huober, Jens, Blohmer, Jens-Uwe, Solbach, Christine, Denkert, Carsten, Nekljudova, Valentina, Link, Theresa and Schneeweiss, Andreas (2020). Chemotherapy (CT)-Induced Anaemia in Patients (PTS) Treated with Dose-Dense Regimen: Results of the Prospectively Randomised Anaemia Substudy from the Neoadjuvant Geparocto Study. Oncol. Res. Treat., 43. S. 21 - 22. BASEL: KARGER. ISSN 2296-5262